tradmap

NGVT Financials Ingevity Corp

12 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has declined 0.8% per year over the past 5 years.
  • Operating margin has expanded, at 35.9% in the latest year.
  • Free cash flow has grown 0.2% per year over the past 5 years.

Financial health

  • Total debt has grown faster than revenue (27.7% vs -0.8% per year).
  • Operating income covered interest expense 5.3× in the latest year, down from 8.4× 5 years ago.
Revenue & net income
-$430M $619M $2B $0 2014 2016 2018 2020 2022 2024
RevenueNet income
Margins (gross / operating / net)
-36% 2% 40% 0% 2014 2016 2018 2020 2022 2024
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-563% -256% 50% 0% 2014 2016 2018 2020 2022 2024
ROEROA
Free cash flow (CFO − capex)
-$29M $122M $274M $0 2014 2016 2018 2020 2022 2024
Free cash flow
Cash vs total debt
$0 $653M $1B 2014 2016 2018 2020 2022 2024
CashTotal debt
Cash flow: operating / investing / financing
-$658M -$145M $369M $0 2014 2016 2018 2020 2022 2024
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $1.2B -$167M 39.5% 35.9% -562.6% -10.1% $274M — $78M
2024 $1.2B -$430M 38.7% 35.5% -220.4% -21.3% $51M — $68M
2023 $1.2B -$5M 36.6% 34.8% -0.9% -0.2% $95M — $96M
2022 $1.7B $212M 34.2% 27.1% 30.3% 7.7% $171M — $77M
2021 $1.4B $118M 36.9% 30.3% 17.5% 4.8% $190M — $275M
2020 $1.2B $181M 38.3% 32.7% 28.3% 7.8% $270M $1.3B $258M
2019 $1.3B $184M 37.3% 30.7% 34.6% 8.6% $161M $1.3B $57M
2018 $1.1B $169M 36.8% 28.3% 49.9% 12.9% $158M $759M $78M
2017 $972M $127M 33.8% 25.0% 45.5% 13.6% $122M $455M $88M
2016 $908M $35M 30.2% 18.0% 27.7% 4.2% $71M $492M $31M
2015 — $80M — — 15.5% 10.2% -$29M — $32M
2014 — $129M — — — 18.0% $37M — $20M

Valuation over time

How the market has priced NGVT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 5.8 11.7 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 1.1 2.2 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is NGVT growing its revenue and profit?

Over the past 5 years, Ingevity Corp's revenue has declined 0.8% per year. These are computed facts, not advice.

How much debt does NGVT have?

As of FY2025, Ingevity Corp reported — of total debt against $78M of cash; operating income covered interest expense 5.3×.

What is NGVT's profit margin?

In FY2025, gross margin was 39.5%, operating margin 35.9%, and net margin -14.3%.

What is NGVT's P/E ratio?

Ingevity Corp's P/E (TTM) is 46.94 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the NGVT stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 7.7× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.